Abstract
Enzyme-resistant long-acting forms of the gut-derived peptide hormones, glucose-dependent insulinotropic polypeptide (GIP), xenin and oxyntomodulin (Oxm) have been generated, and exert beneficial effects on diabetes control and pancreatic islet architecture. The current study has employed alpha-cell lineage tracing in GluCreERT2;ROSA26-eYFP transgenic mice to investigate the extent to which these positive pancreatic effects are associated with alpha- to beta-cell transdifferentiation. Twice-daily administration of (D-Ala2)GIP, xenin-25[Lys13PAL] or (D-Ser2)-Oxm[Lys38PAL] for 10 days to streptozotocin (STZ)-induced diabetic mice did not affect body weight, food intake or blood glucose levels, but (D-Ser2)-Oxm[Lys38PAL] reduced (P<0.05 to P<0.001) fluid intake and circulating glucagon. (D-Ala2)GIP and (D-Ser2)-Oxm[Lys38PAL] also augmented (P<0.05 and P<0.01, respectively) pancreatic insulin content. Detrimental changes of pancreatic morphology induced by STZ in GluCreERT2;ROSA26-eYFP mice were partially reversed by all treatment interventions. This was associated with reduced (P<0.05) apoptosis and increased (P<0.05 to P<0.01) proliferation of beta-cells, alongside opposing effects on alpha-cells, with (D-Ala2)GIP and (D-Ser2)-Oxm[Lys38PAL] being particularly effective in this regard. Alpha-cell lineage tracing revealed that induction of diabetes was accompanied by increased (P<0.01) transdifferentiation of glucagon positive alpha-cells to insulin positive beta-cells. This islet cell transitioning process was augmented (P<0.01 and P<0.001, respectively) by (D-Ala2)GIP and (D-Ser2)-Oxm[Lys38PAL]. (D-Ser2)-Oxm[Lys38PAL] also significantly (P<0.05) promoted loss of alpha-cell identity in favour of other endocrine islet cells. These data highlight intra-islet benefits of (D-Ala2)GIP, xenin-25[Lys13PAL] and (D-Ser2)-Oxm[Lys38PAL] in diabetes with beta-cell loss induced by STZ. The effects appear to be independent of glycaemic change, and associated with alpha- to beta-cell transdifferentiation for the GIP and Oxm analogues.
| Original language | English |
|---|---|
| Article number | 170205 |
| Number of pages | 9 |
| Journal | Peptides |
| Volume | 125 |
| Early online date | 16 Nov 2019 |
| DOIs | |
| Publication status | Published online - 16 Nov 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alpha-cell
- GIP
- GluCreERT2;ROSA26-eYFP mice
- oxyntomodulin (Oxm)
- transdifferentiation
- xenin
Fingerprint
Dive into the research topics of 'Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice'. Together they form a unique fingerprint.Student theses
-
Alpha cells transdifferentiation in the pathophysiology and potential treatment of diabetes
Sarnobat, D.S.-J. (Author), Flatt, P. (Supervisor) & Moffett, C. (Supervisor), Jun 2020Student thesis: Doctoral Thesis
File -
Pharmacological modulation of pancreatic beta-to-alpha cell transdifferentiation in diabetes
Tanday, N. (Author), Flatt, P. (Supervisor) & Moffett, C. (Supervisor), Feb 2019Student thesis: Doctoral Thesis
File
Profiles
-
Charlotte Moffett
- School of Biomedical Sciences - Lecturer in Pharmacology and Molecular Pathology
- Faculty Of Life & Health Sciences - Lecturer
- Biomedical Sciences Research
Person: Academic
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver